tailieunhanh - Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: Retrospective pilot study

Regorafenib is a multi-kinase inhibitor, which was shown to be effective for patients with metastatic colorectal cancer refractory to standard therapies. However, its patterns of response has not yet been fully understood. | Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases Retrospective pilot study

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN